662 related articles for article (PubMed ID: 8263798)
1. Potassium channel openers and blockers: do they possess proarrhythmic or antiarrhythmic activity in ischemic and reperfused rat hearts?
Tosaki A; Szerdahelyi P; Engelman RM; Das DK
J Pharmacol Exp Ther; 1993 Dec; 267(3):1355-62. PubMed ID: 8263798
[TBL] [Abstract][Full Text] [Related]
2. Diabetes and ATP-sensitive potassium channel openers and blockers in isolated ischemic/reperfused hearts.
Tosaki A; Engelman DT; Engelman RM; Das DK
J Pharmacol Exp Ther; 1995 Dec; 275(3):1115-23. PubMed ID: 8531071
[TBL] [Abstract][Full Text] [Related]
3. KATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide.
Ferdinandy P; Szilvássy Z; Droy-Lefaix MT; Tarrade T; Koltai M
Cardiovasc Res; 1995 Nov; 30(5):781-7. PubMed ID: 8595627
[TBL] [Abstract][Full Text] [Related]
4. Effects of cromakalim and glibenclamide on myocardial high energy phosphates and intracellular pH during ischemia-reperfusion: 31P NMR studies.
Docherty JC; Gunter HE; Kuzio B; Shoemaker L; Yang L; Deslauriers R
J Mol Cell Cardiol; 1997 Jun; 29(6):1665-73. PubMed ID: 9220352
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Mg++ manipulation prevents the proarrhythmic activity of cromakalim in ischemic/reperfused diabetic hearts.
Tosaki A; Das DK
J Pharmacol Exp Ther; 1997 Jul; 282(1):309-17. PubMed ID: 9223569
[TBL] [Abstract][Full Text] [Related]
6. Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
Tosaki A; Hellegouarch A
J Am Coll Cardiol; 1994 Feb; 23(2):487-96. PubMed ID: 8294705
[TBL] [Abstract][Full Text] [Related]
7. Proarrhythmic effects of pinacidil are partially mediated through enhancement of catecholamine release in isolated perfused guinea-pig hearts.
D'Alonzo AJ; Zhu JL; Darbenzio RB; Dorso CR; Grover GJ
J Mol Cell Cardiol; 1998 Feb; 30(2):415-23. PubMed ID: 9515018
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic effect of ischemic preconditioning during low-flow ischemia. The role of bradykinin and sarcolemmal versus mitochondrial ATP-sensitive K(+) channels.
Driamov S; Bellahcene M; Ziegler A; Barbosa V; Traub D; Butz S; Buser PT; Zaugg CE
Basic Res Cardiol; 2004 Jul; 99(4):299-308. PubMed ID: 15221348
[TBL] [Abstract][Full Text] [Related]
9. Effect of potassium channel blockade on the anti-ischemic actions of mechanistically diverse agents.
Sargent CA; Smith MA; Dzwonczyk S; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1991 Oct; 259(1):97-103. PubMed ID: 1920138
[TBL] [Abstract][Full Text] [Related]
10. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
[TBL] [Abstract][Full Text] [Related]
11. KATP channel modulators and myocardial damages induced by ischemia-reperfusion: membrane lipids injury and arrhythmias.
Picard S; Rouet R; Duval D; Chesnay F; Gérard JL
J Mol Cell Cardiol; 1998 Dec; 30(12):2613-21. PubMed ID: 9990533
[TBL] [Abstract][Full Text] [Related]
12. Effect of potassium on the action of the KATP modulators cromakalim, pinacidil, or glibenclamide on arrhythmias in isolated perfused rat heart subjected to regional ischaemia.
D'Alonzo AJ; Darbenzio RB; Hess TA; Sewter JC; Sleph PG; Grover GJ
Cardiovasc Res; 1994 Jun; 28(6):881-7. PubMed ID: 7923295
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan: effects of a calcium sensitizer on function and arrhythmias and cyclic nucleotide levels during ischemia/reperfusion in the Langendorff-perfused guinea pig heart.
Du Toit EF; Muller CA; McCarthy J; Opie LH
J Pharmacol Exp Ther; 1999 Aug; 290(2):505-14. PubMed ID: 10411556
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
Grover GJ; D'Alonzo AJ; Garlid KD; Bajgar R; Lodge NJ; Sleph PG; Darbenzio RB; Hess TA; Smith MA; Paucek P; Atwal KS
J Pharmacol Exp Ther; 2001 Jun; 297(3):1184-92. PubMed ID: 11356945
[TBL] [Abstract][Full Text] [Related]
15. Cardioprotective effects of a novel calcium antagonist related to the structure of cromakalim.
Grover GJ; Sleph PG; Dzwonczyk S; McCullough JR
J Pharmacol Exp Ther; 1993 Oct; 267(1):102-7. PubMed ID: 8229736
[TBL] [Abstract][Full Text] [Related]
16. Effects of preconditioning on reperfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischemic/reperfused rat hearts.
Tosaki A; Cordis GA; Szerdahelyi P; Engelman RM; Das DK
J Cardiovasc Pharmacol; 1994 Mar; 23(3):365-73. PubMed ID: 7515978
[TBL] [Abstract][Full Text] [Related]
17. Exogenous hydrogen sulfide (H2S) protects against regional myocardial ischemia-reperfusion injury--Evidence for a role of K ATP channels.
Johansen D; Ytrehus K; Baxter GF
Basic Res Cardiol; 2006 Jan; 101(1):53-60. PubMed ID: 16328106
[TBL] [Abstract][Full Text] [Related]
18. Glyburide-reversible cardioprotective effect of BMS-180448 is independent of action potential shortening.
Grover GJ; D'Alonzo AJ; Hess T; Sleph PG; Darbenzio RB
Cardiovasc Res; 1995 Nov; 30(5):731-8. PubMed ID: 8595620
[TBL] [Abstract][Full Text] [Related]
19. [Cardioprotective effect of cromakalim, a K+ channel opener, on isolated globally ischemic and reperfused rat hearts].
Taki H; Masuda Y; Yoshizumi M; Kitagawa T; Katoh I
Nihon Kyobu Geka Gakkai Zasshi; 1993 Mar; 41(3):438-44. PubMed ID: 8478573
[TBL] [Abstract][Full Text] [Related]
20. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
Nakaya H
Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
[No Abstract] [Full Text] [Related]
[Next] [New Search]
